You are leaving our website

or Decline

How we delivered for our shareholders in 2024

> Expanded gross margin. Increased investment behind our key brands
> Maintained underlying group profit
> Strengthened the skills, experience and expertise on the Executive Committee to align with the long term strategy
> Commenced work to adapt the Company's culture and capabilities to support our ambition to become a high-performing Consumer Healthcare Company
> Good progress made with developing and executing our sustainability strategy

Financial calendar

30Sep 2024 2024 Interim Results

RESULTS, REPORTS & PRESENTATIONS

Results centre